Watch out for these signs of skin cancer, experts say
It can be alarming to see a new spot appear on your skin, especially if it's rapidly growing. Here's what experts need you to know.
Combined organ-specific mRNA and lipid nanoparticle therapy could repair damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
MedPage Today1d
Lung Cancer Screening Population in Real World May Be at Greater Risk for Harm
The randomized NLST had shown that three rounds of annual screening with low-dose CT reduced lung cancer mortality by 20% among current and former smokers as compared with the same number of annual ...
emjreviews.com1d
New Strategy Enhances PD-1 Therapy in Treatment-Resistant Cancers
A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
PMLiVE2d
BMS shares overall survival results for Opdivo in phase 3 lung cancer trial
Bristol Myers Squibb (BMS) has shared positive overall survival (OS) results from a late-stage study of its Opdivo (nivolumab) combination in non-small cell lung cancer (NSCLC).
GEN2d
MD Anderson Receives Nearly $23 Million for Cancer Research and Faculty Recruitment
Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.
What counts as ‘modern’ in health insurance—and who gets to decide?
Health insurance promises coverage for modern treatments, but the definition is vague. Bevacizumab, used for nearly two ...
News Medical2d
CPRIT awards nearly $23 million to MD Anderson for cancer research projects
The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...
The American Journal of Managed Care3d
Banner Year for Bispecifics as Therapies Advance Into the Community Setting
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...
EurekAlert!4d
MD Anderson receives nearly $23 million in CPRIT funding for cancer research, faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...